Skip to content

EFFECTIVENESS OF A NEW BLEACHING AGENT AFTER SINGLE USE IN COMPARISON TO A PLACEBO – A CLINICAL SHORT-TERM STUDY

EFFECTIVENESS OF A NEW BLEACHING AGENT AFTER SINGLE USE IN COMPARISON TO A PLACEBO – A CLINICAL SHORT-TERM STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007636
Enrollment
40
Registered
2015-01-07
Start date
2014-07-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

extrinsic tooth discoloration K03.6

Interventions

Group 1: active agent - 20 subjects get a treatment for 20 minutes with ready-to-use trays and an OTC bleaching agent. Lower und upper jaw are both treated. The gel contains of pthalimidocaproic acid

Sponsors

Sylphar NV
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • 12 natural, frontal teeth • tooth color darker than A2 of the Vita-Shade-Guide

Exclusion criteria

Exclusion criteria: • acute disease • alcoholism • smoker • allergy • pregnant/nursing • acute ginivitis, gingivostomatitis, reduced immunesystem caused by disease (eg HIV) • orthodontic • hypersensitive teeth or exposed dentin tubuli • pathological or defect enamel structure • extensive fillings or crowns on frontal teeth • bleaching

Design outcomes

Primary

MeasureTime frame
Shade improvement of the examined teeth directly after single use treatment with the OTC bleaching agent in comparison to the placebo with the Vita-Shade-Guide.

Secondary

MeasureTime frame
Shade improvement of the examined teeth 24 hours after the treatment in comparison to the placebo with a Vita-Shade-Guide. No tooth sensitivities or muscosairritations directly or after 24 hour after treatment. The sensibilities are assessed using coolant spray and physiological feedback of the subject. Hypersensibilities after the treatment are assessed in comparison to baseline measurements. The mucosa is visually clinical examined by the investigator and irritations and/or ulcerations protocolled. The good acceptance is assessed by an individual (PI) made questionaire "subject questionaire", filled out by the subjects on the last visit.

Countries

Germany

Contacts

Public ContactJulia Domin

Universität Witten/HerdeckeFakultät GesundheitDepartement für Zahnerhaltung und präventive Zahnmedizin

Julia.Domin@uni-wh.de02302 926 653

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026